VASOMUNE
Vasomune Therapeutics is a private biotechnology company developing therapies to target diseases associated with blood vessel (vascular) dysfunction and destabilization. The inner most layer of blood vessels is made up of individual endothelial cells that regulate the passage of immune and inflammatory cells to a site of injury. In many different disease states, dysfunctional vasculature results in an exaggerated inflammatory response. Vascular dysfunction can lead to, or exacerbate many differe... nt diseases such as cardiovascular, renal, pulmonary and oncology. The companyโs lead compound is Vasculotide, a Tie2 receptor agonist that has demonstrated positive therapeutic effect in many different diseases associated with vascular dysfunction. Vasomune Therapeutics, spun out of MaRS Innovation, Sunnybrook Hospital and Health Sciences Centre at the University of Toronto in 2012, is translating a strong foundation of academic science into clinical practice. Vasomuneโs initial programs focus on targeting acute and chronic diseases of the kidney. The lead development program takes aim at treating Acute Kidney Injury (AKI), a significant unmet medical need. While several distinct clinical paths exist for the development of Vasculotide, the decision to pursue AKI is based on a strong, third-party validated preclinical data set and converging evidence that vascular dysfunction lies at the core of AKI.
VASOMUNE
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2012-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.vasomune.com
Total Employee:
11+
Status:
Active
Total Funding:
13.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Vasomune
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Vasomune
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Vasomune
Genome Canada
Genome Canada investment in Seed Round - Vasomune
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners investment in Pre Seed Round - Vasomune
Sunnybrook Research Institute
Sunnybrook Research Institute investment in Pre Seed Round - Vasomune
Official Site Inspections
http://www.vasomune.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago